Provided is a pyrimidine compound of formula (I) useful as a pharmaceutical intermediate, wherein Q is selected from the following groups: -C(R1R2), -(C=0), -BR3. Also provided are a process for preparing said pyrimidine compound, intermediates used in said process, and the use of said pyrimidine compound in the preparation of ticagrelor.
提供的是一种
化学式(I)的
嘧啶化合物,可作为制药中间体使用,其中Q从以下基团中选择:-C(R1R2)、-(C=0)、-BR3。还提供了制备该
嘧啶化合物的方法,用于该方法的中间体,以及在制备
替卡格雷洛时使用该
嘧啶化合物。